by Jordana Choucair | Nov 15, 2022 | Life Sciences
Moderna announced that its new omicron-targeted COVID-19 booster shot performs better against omicron subvariants. New data from a Phase 2-3 clinical trial shows that the vaccine triggered antibody responses against the BA.4 and BA.5 omicron subvariants that were on...
by Jordana Choucair | Nov 15, 2022 | Opioid/Substance Use Disorders
Walmart Inc. has agreed to pay $3.1 billion to settle lawsuits brought by states, cities, and Native American tribes over its role in the opioid crisis. However, the company did not admit liability. Walmart’s agreement follows settlements earlier this month from...
by Jordana Choucair | Nov 15, 2022 | Payers
Highmark Health announced it is partnering with Google Cloud and League to launch its new member portal and mobile app designed to enable easier navigation and more seamless care planning. The new app will use a single sign-on approach to connect users with insurance...
by Jordana Choucair | Nov 15, 2022 | Providers
The American Hospital Association (AHA) released a new report detailing how safety net and charity care hospitals are losing millions due to drug companies cutting off sales of pharmaceuticals discounted under the 340B program to contract pharmacies. The report –...
by Jordana Choucair | Nov 15, 2022 | Public Health/Prevention
Health officials say they’re planning to push this week for people to get boosted against COVID-19 to maximum protection around Thanksgiving. Thus far, overall uptake remains low. According to data from the Centers for Disease Control and Prevention (CDC), only...
by Jordana Choucair | Nov 15, 2022 | Public Health/Prevention
The Biden administration plans to request roughly $10 billion in public health funds from Congress before the end of the year, including about $8.25 billion for COVID-19 vaccines, treatments, and related response efforts. The request, which is reportedly being...
Recent Comments